RxDoctor Payments Data

Virgil Dibiase

Neurology · South Bend, INNPI 1821024043

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 264 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 43 manufacturers reported payments, led by AbbVie at 26.9% of the total. Reporting peaked in 2019 at $1,480 and has fallen 98.9% since, to $16 in 2024.

$3,955in general payments, 2019–2025

Across 264 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • UCB, Inc.$366
  • Biohaven Pharmaceutical Holding Company Ltd.$249
  • Sanofi$208
  • Teva Pharmaceuticals USA, Inc.$150
  • EMD Serono, Inc.$129
  • plus $2K from 37 others

What the payments were for

  • Speaking & faculty fees$642%
  • Food & beverage$3,89198%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,955 in reported general payments places this provider in the 60th percentile of 308 neurology providers in Indiana.

See all neurology providers in Indiana →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Carbidopa-LevodopaCarbidopa/Levodopa17$143

Paid to pharmacies, not to this prescriber.

Other neurology in South Bend

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →